HansaMatrix — Investor Presentation 2022

Apr 7, 2022

I n s p i r e d b y y o u r t r u s t

Nasdaq Webinar

6 April, 2022

Table of Contents

Financial highlights

Business development at HansaMatrix

Questions

11 Lightspace Technologies business update

Financial highlights

Māris Macijevskis, CFO

Revenue data by quarter, million EUR

7

In Q1 2022 HansaMatrix consolidated revenue amounted to 5.99 million EUR demonstrating 2.8% increase compared to Q1 2021 and 23.9% increase compared to Q4 2021

HansaMatrix guidance for 2022

• Increased demand in data networks and industrial sectors;
• Launching manufacturing for new customers, predominantly in industrial sector in Nordic and other EU countries;
• Higher potential business growth is held back by global semiconductor deficit.

REORGANIZATION

Reorganization recently announced is currently postponed because of strategic considerations.

Business development at HansaMatrix

Jānis Sams, CEO

Large supplier of systems and products for the Norwegian aquaculture market

The agreement covers various products that includes, electronics, mechanics, assembly, and testing.

The planned revenue amount is expected up to 5 million EUR in the following 3 years.

The project is now in a pilot and test phase to validate and optimize the delivery before going into volume production.

The new customer related to health and wellness industry

Customer is located in Nordic countries and operates in industrial sector

Strategic match within manufacturing, sourcing and customer support capabilities

HansaMatrix as EMS partner for the full range of electronics in the customer product portfolios

Expected yearly amount of up to 2 million EUR

Manufacturing starting in Q1 2022

Questions (1)

What we need to do to thrive in this complex market environment?

Answer: Active new customer attraction, supplier base diversification, alternative component management approach application, work with component brokers, in advance component sourcing for binding customer orders.

The target sales for 2022 are 9-18% higher y-o-y but Q1 sales are only 2.8% higher y-o-y. Are there lead time delays which will turn sales much higher in the next quarters or this means that supply chain bottlenecks will restrict HMX to attain target?

Answer: In terms of revenue it is expected to reach the announced target of 24-26 million EUR in 2022, as production for new customers is being started, also Q1 2022 revenue is already significantly higher than Q3 and Q4 2021 revenue, implying improvements in component sourcing.

Supply chain bottlenecks, potential neon, and palladium supply crisis for semiconductors...what is the HMX worst case scenario in management eyes?

Answer: Business environment uncertainty has increased significantly after Russia and Ukraine conflict started, nevertheless considering successful work with new customer onboarding and sourcing of components, management under current circumstances consider recently announced guidance to be fulfilled. HansaMatrix will inform investors immediately in case of significant additional component constraints due to the conflict.

Can you list the segments (data networks, Industrial, IoT etc.) by margin value from highest to lowest?

Answer: Value added in manufacturing is more related to product features, higher proportion of automated (machine) work and lower proportin of manual (employee) involvement, as well as degree of supply chain services provision (customer sourcing vs HansaMatrix sourcing), so in all sectors both more and less profitable products are present.

Please explain what exactly HMX will be providing for Lightspace and how much value will be added to HMX by being EMS provider to Lightspace. Will it be high margin segment? Answer: HMX will provide PCBA production services and partial material sourcing

What does the EIB say about this spin off? If they convert the debt, they will lose the possibility to own Lightspace.

Answer: Spin-off is currently postponed due to strategic considerations. Nevertheless from HansaMatrix shareholder value perspective potential Lightspace spin-off situation is equivalent to current HansaMatrix structure as in both cases the same assets are owned by the same shareholders.

If Lightspace will be diluted to level when Ilmars Osmanis and HMX will lose absolute control, there is a possibility that HMX will lose its deal to be EMS provider for Lightspace. What is your opinion on this?

Answer: Currently HansaMatrix ensures PCBA production in prototyping phase and further cooperation will be determined in open competition with other EMS players.

For about 5 years your annual revenue is stuck in 22-24 M euros level. What are the plans for future growth?

Answer: The reason for this is well known Covid 19, and component availability. HMX expect to reach 24-26 M euros during 2022 and continue execute the growth for coming years.

How much of an impact has the war in Ukraine had on HansaMatrix and what are your ways to mitigate that impact?

We expect low impact (less then 5 %), because HMX supply chain does not have direct suppliers and customers in concerned countries.

Lightspace Technologies business update

April 6, 2022 Ilmars Osmanis, Founder, CTO E-mail: invest@lightspace3d.com

Copyright © 2022 Lightspace Labs, Inc. All Rights Reserved.

Business development.

Product news:

• Medical AR headset IG1050-OR1 has been released for production
• Lightspace is accepting shipment orders with 6…8 weeks lead time

Funding news:

• Pre-listing bridge round funding has reached 1.25 M EUR
• Pre-listing bridge round is open till 30.04. to additional investors. Min. amount 100K EUR, terms under NDA.
• Interested parties contact at invest@lightspace3d.com

Update on Lightspace listing process:

• Chosen trading platform Toronto Stock Exchange http://tsx.com
• Listing process expected to take 7…8 months to complete listing
• Lightspace is planning to raise min 10M \$ new capital
• Usage of funds business development, ramp up of manufacturing and further development of technology

• Q: If I own HansaMatrix shares and when Lightspace Technologies will be listed at Toronto Stock Exchange, then do I get free shares.

A: No. After listing Lightspace Holding (100% owned by HansaMatrix) will continue to hold actual Lightspace shares. Only possibility to get «free shares» is to participate in current pre listing bridge round.

• Q: How much Lightspace will be diluted in this financing round and how much is raised?

A: Dilution level depends on company listing valuation. It can not be forecasted at this point. Planned raise of minimum 10M\$ new capital. After successful listing expected increase of value for Lightspace Holding hold Lightspace shares.

• Q: Lightspace spin-off procedure – will it be completed before listing ? A: HansaMatrix AS reorganization process currently is postponed. So also connected to it spin off procedure is postponed.

• Q: Why was TSX-V chosen?

A: Market interest and available liquidity for tech companies. Less listing costs and simpler process in comparison with US based exchanges.

• Q:Will Lightspace spin off procedure be completed before listing? Will there be a SPAC deal? Can you elaborate on the method how HMX shareholders shares will be proportionally transferred to Lightspace?

A: Not necessary. Depends on HMX strategic decisions. SPAC deal is one of options, other options also are considered as for example reverse merger. There are no plans of distributing Lightspace shares to HMX shareholders, un less spin off has been carried out.

• Q: Why "private placement" over IPO – easier procedure or high institutional investor demand? Are you confident to pursue IPO further? Can you specify particular institutional investors participating in the private placement?

A: Easier procedure. Can not comment on details. One more time for interested parties – Lightspace currently attracts Pre-listing bridge round. Details - earlier in presentation.

• Q: What will be the valuation of Lightspace in the private placement, namely, what share for how much?

A: Can not comment at this stage.

• Q: Is this step (fund raising) taken with strong confidence in further collaboration with Planmed, Siemens Healthineers and an industrial customer already contracted for AR supplies in 2022 or with the automotive sector?

A: Yes, biggest Medtech names in market representing around 90% have expressed interest to use Lightspace technology. Industrial market to follow with 1..2 year delay.

• Q:For what exactly funds will be used for - scale-up, raw materials, marketing, further technological development?

A: Business development, Scale-up, Become global, Technological development.

• Q: How much of an impact has the war in Ukraine had on Lightspace, and what are your ways to mitigate that impact?

A: Motivates to work harder. Opens up new business opportunities. Makes global logistic and supply chains more complex. Makes European investment attraction almost impossible.